| Dr Ahmed Ameen Waheed, MD | |
|
2001 Ne 48th Ct, Suite 4, Fort Lauderdale, FL 33308-4512 | |
| (954) 771-3929 | |
| (954) 771-2393 |
| Full Name | Dr Ahmed Ameen Waheed |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 24 Years |
| Location | 2001 Ne 48th Ct, Fort Lauderdale, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487716346 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | ME115833 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Advanced Dialysis Center Of Ft Lauderdale | Oakland park, FL | Dialysis facility |
| East Ft Lauderdale Dialysis Center Llc | Fort lauderdale, FL | Dialysis facility |
| Ft Lauderdale Dixie Dialysis | Oakland park, FL | Dialysis facility |
| Holy Cross Hospital | Fort lauderdale, FL | Hospital |
| Broward Health Imperial Point | Fort lauderdale, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mk Acharya Md Pa And Pm Reddy Md | 7012981350 | 53 |
News Archive
The Wall Street Journal reports on negotiations surrounding a U.N. declaration to be discussed at the High Level Meeting on AIDS scheduled for June 8-10 in New York.
IRIS International, Inc., a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and commercial laboratories worldwide, announced today that its IRIS Molecular Diagnostics (IMD) subsidiary has submitted a 510(k) pre-market notification application to the U.S. Food and Drug Administration (FDA) requesting regulatory clearance for NADiA®ProsVue™, a prostate cancer prognostic test. The test is designed to help physicians identify patients at low risk of cancer recurrence post radical prostatectomy.
The results of Olympus' ongoing joint research program to create an AI-based pathology diagnostic tool with the potential to streamline pathologists' workloads were announced at the Japan Society of Digital Pathology Study annual meeting.
New study conducted by monitoring the brain waves of sleeping adolescents has found that remarkable changes occur in the brain as it prunes away neuronal connections and makes the major transition from childhood to adulthood.
› Verified 3 days ago
| Entity Name | Kidney Group Of South Florida Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730187493 PECOS PAC ID: 2264402700 Enrollment ID: O20040730000451 |
News Archive
The Wall Street Journal reports on negotiations surrounding a U.N. declaration to be discussed at the High Level Meeting on AIDS scheduled for June 8-10 in New York.
IRIS International, Inc., a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and commercial laboratories worldwide, announced today that its IRIS Molecular Diagnostics (IMD) subsidiary has submitted a 510(k) pre-market notification application to the U.S. Food and Drug Administration (FDA) requesting regulatory clearance for NADiA®ProsVue™, a prostate cancer prognostic test. The test is designed to help physicians identify patients at low risk of cancer recurrence post radical prostatectomy.
The results of Olympus' ongoing joint research program to create an AI-based pathology diagnostic tool with the potential to streamline pathologists' workloads were announced at the Japan Society of Digital Pathology Study annual meeting.
New study conducted by monitoring the brain waves of sleeping adolescents has found that remarkable changes occur in the brain as it prunes away neuronal connections and makes the major transition from childhood to adulthood.
› Verified 3 days ago
| Entity Name | Mk Acharya Md Pa & Pm Reddy Md |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780684795 PECOS PAC ID: 7012981350 Enrollment ID: O20040823001373 |
News Archive
The Wall Street Journal reports on negotiations surrounding a U.N. declaration to be discussed at the High Level Meeting on AIDS scheduled for June 8-10 in New York.
IRIS International, Inc., a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and commercial laboratories worldwide, announced today that its IRIS Molecular Diagnostics (IMD) subsidiary has submitted a 510(k) pre-market notification application to the U.S. Food and Drug Administration (FDA) requesting regulatory clearance for NADiA®ProsVue™, a prostate cancer prognostic test. The test is designed to help physicians identify patients at low risk of cancer recurrence post radical prostatectomy.
The results of Olympus' ongoing joint research program to create an AI-based pathology diagnostic tool with the potential to streamline pathologists' workloads were announced at the Japan Society of Digital Pathology Study annual meeting.
New study conducted by monitoring the brain waves of sleeping adolescents has found that remarkable changes occur in the brain as it prunes away neuronal connections and makes the major transition from childhood to adulthood.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ahmed Ameen Waheed, MD 2001 Ne 48th Ct, Suite 4, Fort Lauderdale, FL 33308-4512 Ph: (954) 771-3929 | Dr Ahmed Ameen Waheed, MD 2001 Ne 48th Ct, Suite 4, Fort Lauderdale, FL 33308-4512 Ph: (954) 771-3929 |
News Archive
The Wall Street Journal reports on negotiations surrounding a U.N. declaration to be discussed at the High Level Meeting on AIDS scheduled for June 8-10 in New York.
IRIS International, Inc., a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and commercial laboratories worldwide, announced today that its IRIS Molecular Diagnostics (IMD) subsidiary has submitted a 510(k) pre-market notification application to the U.S. Food and Drug Administration (FDA) requesting regulatory clearance for NADiA®ProsVue™, a prostate cancer prognostic test. The test is designed to help physicians identify patients at low risk of cancer recurrence post radical prostatectomy.
The results of Olympus' ongoing joint research program to create an AI-based pathology diagnostic tool with the potential to streamline pathologists' workloads were announced at the Japan Society of Digital Pathology Study annual meeting.
New study conducted by monitoring the brain waves of sleeping adolescents has found that remarkable changes occur in the brain as it prunes away neuronal connections and makes the major transition from childhood to adulthood.
› Verified 3 days ago
Dr. Gary Meller, MD Nephrology Medicare: Medicare Enrolled Practice Location: 1756 Se 9th St, Fort Lauderdale, FL 33316 Phone: 954-524-0121 | |
Dr. Carlos Eliu Duran-martinez, M.D Nephrology Medicare: Accepting Medicare Assignments Practice Location: 407 Se 9th St, Suite 103, Fort Lauderdale, FL 33316 Phone: 954-463-0112 Fax: 954-463-0117 | |
Edward Michaelson, M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 2030 W Mcnab Rd, Fort Lauderdale, FL 33309 Phone: 954-401-7505 | |
Dr. Lilliam Marie Garcia, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 935 Intracoastal Dr, Fort Lauderdale, FL 33304 Phone: 954-522-8561 Fax: 954-522-6602 | |
Dr. Joshua Michael Larned, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 4725 N Federal Hwy, Suite 401, Fort Lauderdale, FL 33308 Phone: 954-772-2136 | |
Dr. Paul A Feldman, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1900 E Commercial Blvd Ste 201, Fort Lauderdale, FL 33308 Phone: 549-281-1778 Fax: 954-771-1402 | |
Reinaldo Rosario, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 407 Se 9th St, Suite 103, Fort Lauderdale, FL 33316 Phone: 954-463-0112 Fax: 954-463-0117 |